Clinical inertia.

By J. Wofford. Annals of Internal Medicine, 2002

788 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Pediatrics, Perinatology and Child Health

View Paper: https://www.semanticscholar.org/paper/c0978e6acf68f00abdd1c6f1542c876348609e78

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Daniel W. Jones
2. J. Wright
3. S. Hyman

In Endocrinology, Diabetes and Metabolism

1. G. Bakris

Citations in the corpus

• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. (2003, background): “Failure to titrate or combine medications, despite knowing the patient is not at goal BP, represents clinical inertia and must be overcome.(77) Decision support systems (ie, electronic and paper), flow sheets, feedback reminders, and involvement of nurse clinicians and pharmacists can be helpful.”
• The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019) (2019, background): “reported that clinical inertia is a large factor responsible for insufficient treatment of illness free of subjective symptoms such as hypertension, diabetes mellitus and dyslipidemia [1696].”